Click here  or scan the QR code below to share your feedback. Certain pediatric populations remain at substantially increased risk of invasive pneumococcal disease because of underlying medical conditions or altered immune responses. Preterm and low birth weight infants require timely vaccination according to chronological age, 1,2 while children with sickle cell disease and malignancies require careful vaccination planning to ensure optimal protection throughout the course of their illness and treatment.

3,4   In this episode of From Immunity to Protection: Expert Conversations on Pneumococcal Vaccination, the discussion examines the evidence supporting pneumococcal vaccination in these special situations. Experts review the unique challenges associated with vaccination in preterm and low birth weight infants, discuss current recommendations for children with sickle cell disease,…